The Package Insert is sometimes called the Prescribing Information (PI) or the FDA label.What other drugs will affect this medicine?Tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take....
Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the U.S. Food and Drug Administration (FDA) has accepted Eisai’s Biologics License Application (
Eisai Co., Ltd. and Biogen Inc. announced that the U.S. FDA has approved a Supplemental Biologics License Application for LEQEMBI (lecanemab-irmb), allowing for once every four weeks intravenous maintenance dosing for Alzheimer’s disease treatment. This new dosing regimen may ...